Recent research has unveiled new therapeutic targets for aggressive lung cancers. A study identified mutations in KEAP1 and STK11 genes in lung adenocarcinomas that inhibit ferroptosis, suggesting new treatment avenues. Additionally, a gene linked to an aggressive subtype of small-cell lung cancer was discovered, highlighting the need for targeted therapies.